Mass Treatment with Single-Dose Azithromycin for Yaws | Zendy

Natàlia Casamitjana | Zendy; Wendy Houinei | Zendy; Penias Moses | Zendy; August Kapa | Zendy; Raymond Paru | Zendy; Ron D. Hays | Zendy; Sheila A. Lukehart | Zendy; Charmie Godornes | Zendy; Sibauk Bieb | Zendy; Tim Grice | Zendy; Peter Siba | Zendy; David Mabey | Zendy; Sergi Sanz | Zendy; Pedro L. Alonso | Zendy; Kingsley Asiedu | Zendy; Quique Bassat | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mass Treatment with Single-Dose Azithromycin for Yaws

Author(s) -

Natàlia Casamitjana,

Wendy Houinei,

Penias Moses,

August Kapa,

Raymond Paru,

Ron D. Hays,

Sheila A. Lukehart,

Charmie Godornes,

Sibauk Bieb,

Tim Grice,

Peter Siba,

David Mabey,

Sergi Sanz,

Pedro L. Alonso,

Kingsley Asiedu,

Quique Bassat

Publication year - 2015

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1408586

Subject(s) - azithromycin , medicine , titer , serology , population , mass drug administration , vomiting , immunology , antibiotics , environmental health , virus , microbiology and biotechnology , antibody , biology

Mass treatment with azithromycin is a central component of the new World Health Organization (WHO) strategy to eradicate yaws. Empirical data on the effectiveness of the strategy are required as a prerequisite for worldwide implementation of the plan.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research